Life Sciences

A growth hotspot in Europe for Life Sciences development and operations
© Tadas Kazakevičius
Explore: Life Sciences Explore: Life Sciences
  • Why Lithuania
  • Already here
  • Reports & Publications
  • News & Events
  • Contact your advisor
Explore: Life Sciences Explore: Life Sciences
  • Why Lithuania
  • Already here
  • Reports & Publications
  • News & Events
  • Contact your advisor

Lithuania's life sciences
sector at a glance

Lithuania’s Life Sciences sector is gaining prominence. Boosted by an integrated network of science valleys and educational institutions that supply businesses with a pool of top-notch talent that is eager to learn, the sector is accelerating faster than almost anywhere else in Europe.

Life Sciences companies in Lithuania are among the most profitable in the country, with 90% of their output exported worldwide, yet the market remains unsaturated.

  • 85
    number of Life Science companies having manufacturing or R&D operations present
    Source: Moody's Analytics, 2021
  • ~2.5%
    percentage of Lithuania‘s GDP generated by the sector
    Source: Lithuanian Biotechnology Association, 2020
  • 32nd
    in the Global Biotechnology Innovation ranking
    Source: Scientific American Worldview, 2020
  • 90%
    percentage of all pharmaceutical and healthcare production exported, with produce going to over 100 countries
    Source: Statistics Lithuania, 2020
  • Main export markets:
    USA (29%), Germany (14%), China (6.3%), UK (4.7%) and others (46%)
    Source: Statistics Lithuania, 2020
  • Priority sector

    Life Sciences is high on the political agenda, which means we offer exceptional support for soft-landing and are dedicated to deliver.

    Source: Lithuania’s Life Sciences Strategy approved by the Parliament, 2018 September

  • FDA-approved regulatory authorities

    In 2018 Lithuania entered into a Mutual Recognition Agreement with the FDA, under which the FDA recognized the Lithuanian State Medicine Control Agency as capable of conducting inspections that meet US requirements.

    Source: US Food & Drug Administration, 2018

A range of benefits for Life Sciences companies

  • Benefits
    Attractive financial incentives for both R&D and manufacturing activities
  • Benefits
    Exceptional government support to ensure smooth business operations in the country
  • Benefits
    A pool of highly skilled and motivated talent ready to create added value for your business
  • Benefits
    A welcoming and value-driven ecosystem, with support available to ensure a fast and efficient soft-landing

Main competencies in Lithuania’s ecosystem

  • Cell and gene therapy
    Cell & gene therapy
  • Biological others
    Biologics Others
  • Pharma
    Pharma / drug delivery
  • Health diagnostics
    Medical & Diagnostics
  • Medtech
    MedTech & Engineering
  • Lasers
    Digital Health & Laser technologies

Emerging Life Sciences competencies

  • Immunotherapy products
    Immunotherapy products
  • Generics
  • Antibodies
  • Nucleid acid drugs
    Nucleid acid drugs

Already here

Financial incentives and government support

  • Financial Incentive for Large Scale Projects
  • 3 Times Deductable Expenses
  • Patent Box
  • Free Economic Zones
  • EU support

Related materials
to download

What’s happening
in the sector

Have questions? Contact us
Julija Lukaitytė
Head of Life Sciences Team LinkedIn icon
Contact me
Get in touch

    Julija Lukaitytė Head of Life Sciences Team
    Thank you!

    Thanks for reaching out to us, this means a lot! We will get back to you shortly.

    Meanwhile, we invite you to discover what’s new in the Lithuanian business landscape.

    Vilnius panorama